Results 161 to 170 of about 67,791 (261)

ABCB1, SLC22A1, COMT, and OPRM1 genotypes: Study of their influence on plasma methadone levels and clinical response to methadone maintenance treatment in opioid use disorder. [PDF]

Fundam Clin Pharmacol
Ait Tayeb AEK, Laforgue EJ, Schreck B, Grall-Bronnec M, Hardouin JB, Leboucher J, OPAL Group.   +6 more
europepmc   +1 more source

Heart Rate Variability for Supplementing Withdrawal Assessment in Patients with Opioid Dependence: An Exploratory Study. [PDF]

Indian J Psychol Med
Sarkar S, Kochhar KP, Sood E, Chandran D, Jangra S, Verma A.   +5 more
europepmc   +1 more source

Anti-HCV testing acceptance and seroconversion rates among people who use drugs and are under opiate substitution treatment (Hippocrates Epidemic Detection System)

, 2023
Olga Anagnostou, Katerina Micha, George Tsitsanis, Argyro Karakosta, Γεωργία Παπαδοπούλου, Eleni Panopoulou, Christos Danopoulos, Charikleia Tsatsaroni, Nikolaos Avgerinos   +8 more
openalex   +2 more sources

Improving hospital-based opioid substitution therapy (iHOST): protocol for a mixed-methods evaluation [version 2; peer review: 2 approved]

NIHR Open Research
Background Opioid substitution therapy (also known as ‘opioid agonist therapy’ or ‘medication treatment of opioid use disorder’) is associated with improved health and social outcomes for people who use heroin and other illicit opioids.
Marisha Wickremsinhe, Dan Lewer, Adam Burns, Michael Brown, Rosalind Gittins, Niamh Eastwood, Vivian Hope, Adam Holland, Penny Lewthwaite, Aubrey Ko, Adrian Noctor, Ann-Marie Morris, Jenny Scott, Andrew Preston, Sedona Sweeney, Erica Smith, Magdalena Harris, Nerissa Tilouche   +17 more
doaj  

Extended-Release Buprenorphine Could Overcome Barriers to Medical Treatment of Opioid Use Disorder in At-Risk Populations. [PDF]

HCA Healthc J Med
Davis SA, Verrastro G, Fagan EB.
europepmc   +1 more source

For a renewed harm reduction model. [PDF]

Harm Reduct J
Chappard P, Pourchon F.
europepmc   +1 more source

Addressing the Health Needs of People Who Inject Drugs: A Descriptive Analysis of an Inpatient Integrated Care Team Within an Acute Hospital in Scotland. [PDF]

Open Forum Infect Dis
Chung A, Johnson K, Mulloy B, Mackintosh CL.   +3 more
europepmc   +1 more source

Lowering the Threshold. Models of Accessible Methadone and Buprenorphine Treatment [PDF]

, 2010
Keeney, Elizabeth, Saucier, Roxanne
core  

The role of attachment and personality traits in choosing opiate addiction replacement therapy. [PDF]

Sci Rep
Gizdic A, Antičević V, Brajević-Gizdić I.   +2 more
europepmc   +1 more source

Mobile telephone-delivered Contingency Management (mCM) to reduce heroin use in individuals with opioid use disorder (CM4OUD): A feasibility study protocol. [PDF]

PLoS One
Getty CA, Strang J, Carr E, Dallery J, Metrebian N.   +4 more
europepmc   +1 more source